Sources

7 Total Sources

Researchers Trace Daraxonrasib Resistance in 66 Pancreatic Cancer Patients as Drug Often Fails After 7 Months

Far Left25%
Left75%
The New York Times2h ago
Researchers Present Study on Pancreatic Cancer Drug Daraxonrasib Resistance
The Good Men Project15h ago
FDA Approves Breakthrough Pancreatic Cancer Drug – An Oncologist Explains How Daraxonrasib Nearly Doubles Survival - The Good Men Project
WBUR News2h ago
How a Mass. researcher's lab made a breakthrough in pancreatic cancer treatment | WBUR News
The Boston Globe2h ago
Pancreatic cancer breakthrough: daraxonrasib doubles survival
ResearchGate2h ago
PDF) Daraxonrasib and the era of pan-RAS inhibition: mechanisms, clinical advances, and resistance landscapes
hospitalsmagazine.com2h ago
New pancreatic cancer drug at UCHICAGO Medicine
drvinayprasad.com20h ago
Pancreas cancer: How 92% becomes 45% in 15%